The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 31, 2022 | Bash Alan | Chief Executive Officer, Director | Disposed to issuer(D) | 575K | — | — |
| May 31, 2022 | Fuhrman Alan | Director | Disposed to issuer(D) | 10K | — | — |
| May 31, 2022 | Fuhrman Alan | Director | Disposed to issuer(D) | 247K | — | — |
| May 31, 2022 | Fuhrman Alan | Director | Disposed to issuer(D) | 23K | — | — |
| May 31, 2022 | Wigginton Jon Marc | Director | Disposed to issuer(D) | 20K | — | — |
| May 31, 2022 | Wooldridge James | Chief Medical Officer | Disposed to issuer(D) | 96K | — | — |
| May 31, 2022 | Wooldridge James | Chief Medical Officer | Disposed to issuer(D) | 151K | — | — |
| May 31, 2022 | Wooldridge James | Chief Medical Officer | Disposed to issuer(D) | 27K | — | — |
| May 31, 2022 | Wooldridge James | Chief Medical Officer | Disposed to issuer(D) | 101K | — | — |
| May 31, 2022 | Wooldridge James | Chief Medical Officer | Disposed to issuer(D) | 55K | — | — |
| May 31, 2022 | Dolski Robert | Chief Financial Officer | Disposed to issuer(D) | 150K | — | — |
| May 31, 2022 | Dolski Robert | Chief Financial Officer | Disposed to issuer(D) | 27K | — | — |
| May 31, 2022 | Dolski Robert | Chief Financial Officer | Disposed to issuer(D) | 101K | — | — |
| May 31, 2022 | Yan Joy | Director | Disposed to issuer(D) | 20K | — | — |
| May 31, 2022 | Colabuono Peter | Director | Disposed to issuer(D) | 20K | — | — |
| May 31, 2022 | Colabuono Peter | Director | Disposed to issuer(D) | 10K | — | — |
| May 31, 2022 | Isacoff Oren | Director | Disposed to issuer(D) | 20K | — | — |
| May 31, 2022 | Isacoff Oren | Director | Disposed to issuer(D) | 10K | — | — |
| May 31, 2022 | Flaherty Keith T. | Director | Disposed to issuer(D) | 4K | — | — |
| May 31, 2022 | Flaherty Keith T. | Director | Disposed to issuer(D) | 23K | — | — |
| May 31, 2022 | Flaherty Keith T. | Director | Disposed to issuer(D) | 10K | — | — |
| May 31, 2022 | Powell Michael | Director | Disposed to issuer(D) | 30K | — | — |
| May 31, 2022 | Powell Michael | Director | Disposed to issuer(D) | 30K | — | — |
| May 31, 2022 | Powell Michael | Director | Disposed to issuer(D) | 10K | — | — |
| May 16, 2022 | Goodman Corey S | 10% Owner | Sell(S) | 96K | $10.45 | $1.0M |
| May 13, 2022 | Goodman Corey S | 10% Owner | Sell(S) | 36K | $10.45 | $375K |
| May 12, 2022 | venBio Global Strategic Fund II L.P. | 10% Owner | Sell(S) | 125K | $10.39 | $1.3M |
| May 11, 2022 | venBio Global Strategic Fund II L.P. | 10% Owner | Sell(S) | 18K | $10.38 | $184K |
| May 10, 2022 | venBio Global Strategic Fund II L.P. | 10% Owner | Sell(S) | 19K | $10.38 | $194K |
| May 9, 2022 | venBio Global Strategic Fund II L.P. | 10% Owner | Sell(S) | 18K | $10.37 | $183K |
| May 6, 2022 | venBio Global Strategic Fund II L.P. | 10% Owner | Sell(S) | 48K | $10.37 | $501K |
| May 5, 2022 | venBio Global Strategic Fund II L.P. | 10% Owner | Sell(S) | 21K | $10.37 | $215K |
| May 4, 2022 | venBio Global Strategic GP II, Ltd. | 10% Owner | Sell(S) | 38K | $10.37 | $389K |
| May 3, 2022 | venBio Global Strategic GP II, Ltd. | 10% Owner | Sell(S) | 79K | $10.37 | $824K |
| May 2, 2022 | venBio Global Strategic GP II, Ltd. | 10% Owner | Sell(S) | 154K | $10.38 | $1.6M |
| Apr 29, 2022 | venBio Global Strategic Fund II L.P. | 10% Owner | Sell(S) | 69K | $10.38 | $719K |
| Apr 28, 2022 | venBio Global Strategic Fund II L.P. | 10% Owner | Sell(S) | 73K | $10.38 | $762K |
| Apr 27, 2022 | venBio Global Strategic Fund II L.P. | 10% Owner | Sell(S) | 47K | $10.38 | $492K |
| Apr 26, 2022 | venBio Global Strategic GP II, L.P. | 10% Owner | Sell(S) | 65K | $10.38 | $671K |
| Apr 25, 2022 | venBio Global Strategic GP II, L.P. | 10% Owner | Sell(S) | 28K | $10.39 | $287K |
| Apr 22, 2022 | venBio Global Strategic GP II, L.P. | 10% Owner | Sell(S) | 37K | $10.39 | $389K |
| Apr 21, 2022 | venBio Global Strategic GP II, Ltd. | 10% Owner | Sell(S) | 62K | $10.38 | $646K |
| Apr 20, 2022 | venBio Global Strategic GP II, Ltd. | 10% Owner | Sell(S) | 86K | $10.39 | $889K |
| Apr 19, 2022 | venBio Global Strategic GP II, Ltd. | 10% Owner | Sell(S) | 400K | $10.42 | $4.2M |
| Mar 1, 2022 | Bash Alan | Chief Executive Officer, Director | Grant(A) | 575K | — | $0 |
| Feb 25, 2022 | Novo Holdings A/S | 10% Owner | Sell(S) | 300 | $2.70 | $810 |
| Feb 24, 2022 | Novo Holdings A/S | 10% Owner | Sell(S) | 6K | $2.83 | $17K |
| Feb 23, 2022 | Novo Holdings A/S | 10% Owner | Sell(S) | 2K | $2.90 | $5K |
| Jan 30, 2022 | Wigginton Jon Marc | Director | Grant(A) | 20K | — | $0 |
| Jan 27, 2022 | Wooldridge James | Chief Medical Officer | Grant(A) | 101K | — | $0 |
| Jan 27, 2022 | Dolski Robert | Chief Financial Officer | Grant(A) | 101K | — | $0 |
| Dec 16, 2021 | Yan Joy | Director | Grant(A) | 20K | — | $0 |
| Oct 27, 2021 | Fuhrman Alan | See Remarks, Director | Grant(A) | 247K | — | $0 |
| Aug 9, 2021 | Powell Michael | Director | Grant(A) | 30K | — | $0 |
| Aug 4, 2021 | Dolski Robert | Chief Financial Officer | Grant(A) | 27K | — | $0 |
| Aug 4, 2021 | Wooldridge James | Chief Medical Officer | Grant(A) | 27K | — | $0 |
| Aug 4, 2021 | Chaudhary Kleem | Chief Business Officer | Grant(A) | 27K | — | $0 |
| Aug 4, 2021 | Labinger Barry | President and CEO, Director | Grant(A) | 86K | — | $0 |
| Jun 18, 2021 | Krieg Arthur M | Chief Scientific Officer | Buy(P) | 7K | $6.04 | $44K |
| Jun 16, 2021 | Flaherty Keith T. | Director | Grant(A) | 10K | — | $0 |
| Jun 16, 2021 | Fuhrman Alan | Director | Grant(A) | 10K | — | $0 |
| Jun 16, 2021 | Isacoff Oren | Director | Grant(A) | 10K | — | $0 |
| Jun 16, 2021 | Colabuono Peter | Director | Grant(A) | 10K | — | $0 |
| Jun 16, 2021 | Powell Michael | Director | Grant(A) | 10K | — | $0 |
| Jun 16, 2021 | Krieg Arthur M | Chief Scientific Officer | Buy(P) | 4K | $6.18 | $22K |
| May 28, 2021 | Krieg Arthur M | Chief Scientific Officer | Other(J) | 68K | — | $0 |
| May 28, 2021 | Krieg Arthur M | Chief Scientific Officer | Other(J) | 68K | — | $0 |
| May 28, 2021 | Krieg Arthur M | Chief Scientific Officer | Other(J) | 68K | — | $0 |
| May 18, 2021 | Krieg Arthur M | Chief Scientific Officer | Buy(P) | 25K | $6.97 | $174K |
| Mar 4, 2021 | Wooldridge James | Chief Medical Officer | Grant(A) | 55K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).